Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
WHAT IT'S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic monitoring technology.
Established in 2017, Nutromics has been developing a "lab-in-a-patch," which uses DNA sensor technology to track multiple targets, such as...
Medtech startup Nutromics has received a $14 million investment from strategic investors, including Dexcom Ventures, VU Venture Partners, and Artesian Investments.
Founded in 2017, the company is developing a continuous diagnostic monitoring platform called lab-in-a-patch that uses DNA sensor technology to track multiple targets in the human body, including disease biomarkers and hard-to-dose...
Australian med tech startup Nutromics has named US-based Dr Agim Beshiri as its first chief medical officer.
Dr Beshiri has over two decades of experience in the diagnostic space, specialising in laboratory medicine and internal medicine. He was recently a senior medical director at Abbott Laboratories, the maker of the Freestyle Libre and Lingo biosensors.
He will be leading Nutromics'...
Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million).
WHAT IT DOES
Founded in 2018, the startup is developing continuous molecular monitoring (CMM) platform technology that is able to track multiple...
